Literature DB >> 4032263

Analgesic potencies of morphine 3- and 6-sulfates after intracerebroventricular administration in mice: relationship to structural characteristics defined by mass spectrometry and nuclear magnetic resonance.

C E Brown, S C Roerig, V T Burger, R B Cody, J M Fujimoto.   

Abstract

Morphine 3-sulfate, which carries a polar, acidic group at the 3-position much like morphine, does not differ greatly in analgesic potency from morphine following intracerebroventricular administration. This differs from the non-ionizable 3-methyl and 3-ethyl ethers, which are less potent analgesics than morphine. Morphine 6-sulfate, which differs from morphine by having an ionizable group at carbon-6 at physiological pH, is a more potent analgesic than morphine following intracerebroventricular administration. Variations in analgesic potency following modifications at the hydroxyl groups appear only to reflect alterations in point charges rather than structural alterations.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4032263     DOI: 10.1002/jps.2600740804

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  5 in total

1.  Antinociceptive effects of the 6-O-sulfate ester of morphine in normal and diabetic rats: Comparative role of mu- and delta-opioid receptors.

Authors:  Jai Shankar K Yadlapalli; Benjamin M Ford; Amit Ketkar; Anqi Wan; Narasimha R Penthala; Robert L Eoff; Paul L Prather; Maxim Dobretsov; Peter A Crooks
Journal:  Pharmacol Res       Date:  2016-09-13       Impact factor: 7.658

2.  Characterization of three crystalline forms (VIII, XI, and XII) and the amorphous form (V) of delavirdine mesylate using 13C CP/MAS NMR.

Authors:  P Gao
Journal:  Pharm Res       Date:  1998-09       Impact factor: 4.200

3.  The analgesic activity of morphine-6-glucuronide.

Authors:  R Osborne; P Thompson; S Joel; D Trew; N Patel; M Slevin
Journal:  Br J Clin Pharmacol       Date:  1992-08       Impact factor: 4.335

4.  Sulfation of opioid drugs by human cytosolic sulfotransferases: metabolic labeling study and enzymatic analysis.

Authors:  Katsuhisa Kurogi; Andriy Chepak; Michael T Hanrahan; Ming-Yih Liu; Yoichi Sakakibara; Masahito Suiko; Ming-Cheh Liu
Journal:  Eur J Pharm Sci       Date:  2014-05-14       Impact factor: 4.384

5.  Comparisons of In Vivo and In Vitro Opioid Effects of Newly Synthesized 14-Methoxycodeine-6-O-sulfate and Codeine-6-O-sulfate.

Authors:  Ferenc Zádor; Amir Mohammadzadeh; Mihály Balogh; Zoltán S Zádori; Kornél Király; Szilvia Barsi; Anna Rita Galambos; Szilvia B László; Barbara Hutka; András Váradi; Sándor Hosztafi; Pál Riba; Sándor Benyhe; Susanna Fürst; Mahmoud Al-Khrasani
Journal:  Molecules       Date:  2020-03-17       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.